Data Mining on Large Health Record Databases for Detecting Adverse Reactions: Which Events to Monitor? G. Trifiro’A. ParienteA. Fourrier-Reglat Abstract 03 January 2013 Pages: 885 - 885
The Beginning of Pharmacovigilance in a Public Industry J. P. CarvalhoA. C. AbrittaA. V. Luna Abstract 03 January 2013 Pages: 885 - 885
Case 02-2007 “A 62 Year Old Patient with Hypertension Crisis, Tachycardia and Severe Headache” P. LipszycM. V. CerisolaF. Lipszyc Abstract 03 January 2013 Pages: 885 - 885
Analysis of Drug Adverse Reaction Relief Applications in Taiwan from 1999–2007 L. Kuo-HuaY. Hsiu-ChiungL. Min-Shung Abstract 03 January 2013 Pages: 885 - 885
Where Does the Evidence for Guidelines Come From? An Example of Monitoring for the Adverse Renal Effects of ACE Inhibitors J. J. ColemanS. E. McDowellR. E. Ferner Abstract 03 January 2013 Pages: 885 - 885
An Observational Study of Adverse Drug Reactions in Patients of a New Zealand General Hospital: Incidence of Hyperuricaemia C. AntonB. S. HebronH. J. Hebron Abstract 03 January 2013 Pages: 885 - 885
MedDRA as a Standard: Approach to Version Updates and Primary SOC Allocation T. Moraleda Abstract 03 January 2013 Pages: 885 - 885
Moclobemide, Citalopram and Hyponatraemia C. AntonB. S. HebronH. J. Hebron Abstract 03 January 2013 Pages: 885 - 885
Non-Drug Related Adverse Complaints in Volunteers to Phase I Studies and in Normal Population L. AlmeidaH. GamaP. Soares-da-Silva Abstract 03 January 2013 Pages: 885 - 885
Pilot Case Control Study of Chinese Herbs and Liver Toxicity D. Shaw Abstract 03 January 2013 Pages: 885 - 885
Comparison of Adverse Reactions Notified with Three Step 2 Analgesic Associations in France: Dextropropoxyphen + Acetaminophen, Tramadol + Acetaminophen, Codeine + Acetaminophen N. TavassoliG. DurrieuJ. L. Montastruc Abstract 03 January 2013 Pages: 885 - 885
Paresthesia with Spiramycin Treatment H. ThéophileB. JulliacF. Haramburu Abstract 03 January 2013 Pages: 885 - 885
Genotyping in the TDM Laboratory — Necessary for Pharmacovigilance? A. HaderD. MelchnerE. Haen Abstract 03 January 2013 Pages: 885 - 885
Episodes of Amnesia and Other Neuropsychiatric Disturbances During the Use of Zolpidem and Other Non-Benzodiazepine Hypnotics R. MeyboomM. DoraiswamyA. Viklund Abstract 03 January 2013 Pages: 885 - 885
Reports of Seizures Caused by Drugs M. R. GruszyckiD. A. AlbaR. M. Osicka Abstract 03 January 2013 Pages: 885 - 885
Adverse Drug Reactions and Off-Label Drug Use in Paediatric Patients: A One-Year Survey of the French Pharmacovigilance Database G. DurrieuV. RaoulJ. Montastruc Abstract 03 January 2013 Pages: 885 - 885
Potential Drug-Drug Interactions in a Cohort of Patients Who Underwent Radiodiagnostic Procedures: An In-Hospital Survey F. LapiM. MoschiniA. Vannacci Abstract 03 January 2013 Pages: 885 - 885
Risk Minimisation Activities to Minimise Drug-Related Risks: An Overview of Current Practice T. J. GiezenF. MoralB. J. van Zwieten-Boot Abstract 03 January 2013 Pages: 885 - 885
Master in Pharmacovigilance: A Training Programme to Improve the Quality of a Drug Surveillance System M. Di PirroM. MoschiniA. Vannacci Abstract 03 January 2013 Pages: 885 - 885
Memory loss and Confusion with Statins — An Analysis of Spontaneous Case Reports Using the DoTs Classification Scheme C. AntonA. R. CoxR. E. Ferner Abstract 03 January 2013 Pages: 885 - 885
Patients Starting Anti-Obesity Drugs Carry Higher Psychiatric and Cardiovascular Baseline Risk M. J. WillemenA. K. Mantel-TeeuwisseM. C. Sturkenboom Abstract 03 January 2013 Pages: 885 - 885
Adverse Drug Reactions with Donepezil: Analysis of the French Pharmacovigilance Database S. BabaiW. E. BourzamH. Le Louët Abstract 03 January 2013 Pages: 885 - 885
Psychiatric Disorders with Anti-TNFalpha Treatment: An Adverse Drug Reaction to Keep in Mind H. ThéophileB. DebrayF. Haramburu Abstract 03 January 2013 Pages: 885 - 885
Recurrent Upper Gastrointestinal Bleeding Associated with Acenocoumarol and Enoxaparin G. A. KellerA. YufraG. Di Girolamo Abstract 03 January 2013 Pages: 885 - 885
Worldwide Pharmacovigilance of a Biosimilar Product Containing Epoetin (Hemax®) H. FerroH. DonatoE. Gonzalez Abstract 03 January 2013 Pages: 885 - 885
Acute Hypersensitivity Reactions to Andrographis paniculata Containing Products, as Reported in International Pharmacovigilance M. FarahR. MeyboomM. Ploën Abstract 03 January 2013 Pages: 885 - 885
HMG CoA Reductase Inhibitors and impotence: Results of a Case/Noncase study in the French PharmacoVigilance Database C. DoE. HuygheH. Bagheri Abstract 03 January 2013 Pages: 885 - 885
Evidences of Efficacy and Safety of Over-the-Counter Medications for Cough Registered in Brazil: A Challenge to Pharmacovigilance A. M. M. ReisA. Figueras Abstract 03 January 2013 Pages: 885 - 885
Analysis of Pediatric Use Information on Package Insert of Antimicrobial Drugs A. C. S. GonçalvesC. M. CaixetaA. M. M. Reis Abstract 03 January 2013 Pages: 885 - 885
Cefepime Neurotoxicity Identified by Intensified Surveillance at Brazilian University Hospital M. C. P. SouzaMd. D. G. SilvaA. M. M. Reis Abstract 03 January 2013 Pages: 885 - 885
Pharmacovigilance within the Internal Medicine Division of Argerich Hospital M. PonteG. Di GirolamoN. Terragno Abstract 03 January 2013 Pages: 885 - 885
Voriconazole-Induced Leaky Capillary Syndrome (Case Report) M. PonteDi G. GirolamoN. Terragno Abstract 03 January 2013 Pages: 885 - 885
Drug Induced — Hepatotoxicity M. PonteG. Di GirolamoN. Terragno Abstract 03 January 2013 Pages: 885 - 885
Evidence to Support the Regulation Decision for the Usage of Pergolide in Patients with Parkinson’s Disease in Taiwan C. GauP. LiiC. Hsu Abstract 03 January 2013 Pages: 885 - 885
Evaluating Prescriber Characteristics Associated with NSAID Prescribing Practices in the Netherlands D. LaytonP. SouvereinS. Shakir Abstract 03 January 2013 Pages: 885 - 885
Ventricular Arrhythmia and Sudden Unexpected Death and Domperidone C. van NoordJ. DielemanM. Sturkenboom Abstract 03 January 2013 Pages: 885 - 885
Assessment of Blood Products Demand in the Treatment of Adverse Drug Reactions in German Hospitals M. RottenkolberS. SchmiedlJ. Hasford Abstract 03 January 2013 Pages: 885 - 885
Pharmacovigilance from the University: Experience in the Report of Adverse Events and Lack of Efficiency P. S. LipszycS. J. SettonD. Scublinsky Abstract 03 January 2013 Pages: 885 - 885
Pharmacovigilance and Patient Safety — Results of the German Net of Regional Pharmacovigilance Centers J. HasfordM. RottenkolberP. A. Thuermann Abstract 03 January 2013 Pages: 885 - 885
Hospital Admissions due to Adverse Drug Reactions: EMIR, a Nationwide Study G. Miremont-SalaméA. Bénard-LaribièreFrench Pharmacovigilance Centres N6 Abstracts 03 January 2013 Pages: 885 - 885
A Tool for Preventing Medication Errors Due to Similar Labeling and Packaging of Drugs in a Brazilian Teaching Hospital M. C. SakaiP. Luppi JrE. Ribeiro Abstract 03 January 2013 Pages: 885 - 885
Non-Drug Adverse Symptoms are Influenced by the Personality Trait Anxiety L. AlmeidaH. GamaP. Soares-da-Silva Abstract 03 January 2013 Pages: 885 - 885
Subjects High in Anxiety and Low in Perceived Self-Efficacy Tend to Report More Adverse Events in Phase I studies L. AlmeidaH. GamaP. Soares-da-Silva Abstract 03 January 2013 Pages: 885 - 885
Infovigilance: Notification of Errors from Official Drug Information sources M. C. HussonL. FusierM. Ollagnier Abstract 03 January 2013 Pages: 885 - 885
Policy for the Management of the Pharmacovigilance Unified system in the Province Of Cordoba (SUFV) K. GaticaM. RencoretG. Aramburu Abstract 03 January 2013 Pages: 885 - 885
Potential Drug-Drug Interactions in Patients with coronary Artery Disease S. R. SecoliN. DanziA. M. M. Reis Abstract 03 January 2013 Pages: 885 - 885
Evaluation of the Reports Related to Drug Quality Problems from January 2001 to December 2007 in a Brazilian Teaching Hospital M. C. SakaiP. S. K. TakahashiE. Ribeiro Abstract 03 January 2013 Pages: 885 - 885
Finasteride-Associated Central Serious Chorioretinopathy R. LombardoA. LoraschiM. Cosentino Abstract 03 January 2013 Pages: 885 - 885
Collaborative Hospital-Based Surveillance Network of Drug-Induced Pancreatitis: A Feasibility Study in Italy A. LoraschiA. VolontèM. Cosentino Abstract 03 January 2013 Pages: 885 - 885
Intensive Monitoring of Adverse Drug Reactions in HIV Patients: A Hospital-Based Study in Italy A. LoraschiA. VolonteM. Cosentino Abstract 03 January 2013 Pages: 885 - 885
